BONO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 2.195
EU - Europa 1.701
AS - Asia 1.317
SA - Sud America 233
AF - Africa 46
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.498
Nazione #
US - Stati Uniti d'America 2.142
SG - Singapore 538
RU - Federazione Russa 495
IT - Italia 494
CN - Cina 277
DE - Germania 226
BR - Brasile 190
VN - Vietnam 136
FI - Finlandia 131
HK - Hong Kong 125
FR - Francia 82
PL - Polonia 76
GB - Regno Unito 59
IN - India 49
JP - Giappone 41
NL - Olanda 29
CA - Canada 27
BD - Bangladesh 21
SE - Svezia 21
MX - Messico 20
PK - Pakistan 16
RO - Romania 15
KR - Corea 14
IE - Irlanda 13
TR - Turchia 13
ZA - Sudafrica 13
AT - Austria 12
ES - Italia 12
IQ - Iraq 12
EC - Ecuador 9
IR - Iran 9
MY - Malesia 9
NP - Nepal 9
AR - Argentina 8
EG - Egitto 8
ID - Indonesia 8
BE - Belgio 6
KE - Kenya 6
UA - Ucraina 6
UZ - Uzbekistan 6
CI - Costa d'Avorio 5
CO - Colombia 5
MA - Marocco 5
SA - Arabia Saudita 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
PY - Paraguay 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
MM - Myanmar 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
UY - Uruguay 3
AL - Albania 2
CH - Svizzera 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MO - Macao, regione amministrativa speciale della Cina 2
SN - Senegal 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FJ - Figi 1
GT - Guatemala 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
SI - Slovenia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 5.498
Città #
Ashburn 374
Singapore 323
Chandler 155
Fairfield 147
San Jose 146
Hong Kong 114
Helsinki 109
Palermo 107
Moscow 105
Munich 92
Council Bluffs 82
The Dalles 77
Woodbridge 77
Rome 76
Beijing 68
Houston 62
Zgierz 62
Wilmington 61
New York 55
Seattle 54
Los Angeles 41
Cambridge 40
Tokyo 39
Ho Chi Minh City 38
Dallas 35
Hefei 33
Hanoi 32
Medford 31
Ann Arbor 30
Frankfurt am Main 30
Lauterbourg 29
Santa Clara 29
Chicago 28
Des Moines 28
Buffalo 24
São Paulo 19
Princeton 18
Orem 17
Bremen 16
Milan 14
San Diego 14
Lawrence 13
London 13
Ludwigshafen am Rhein 13
Dublin 12
Seoul 12
Kitzingen 11
Lappeenranta 11
Warsaw 11
Nuremberg 10
Phoenix 10
Atlanta 9
Chennai 9
Haiphong 9
Johannesburg 9
Montreal 9
Naples 9
Boardman 8
Brooklyn 8
Kumar 8
Mumbai 8
Pune 8
Turin 8
Altamura 7
Aversa 7
Denver 7
Monza 7
Redwood City 7
Salt Lake City 7
San Francisco 7
Schiffdorf 7
Tappahannock 7
Baghdad 6
Bexley 6
Brussels 6
Cairo 6
Jinan 6
Kuala Lumpur 6
Manchester 6
Messina 6
Querétaro 6
Rio de Janeiro 6
Toronto 6
Venice 6
Abidjan 5
Boston 5
Cagliari 5
Da Nang 5
Falkenstein 5
Mexico City 5
Paris 5
Redondo Beach 5
Stockholm 5
Tashkent 5
Volla 5
Biên Hòa 4
Catania 4
Changsha 4
Columbus 4
Falls Church 4
Totale 3.359
Nome #
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 316
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 275
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer 230
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 225
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 221
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 218
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 217
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 213
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL 210
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 209
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 203
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 197
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 193
Multigene panel testing in Hereditary Breast and Ovarian Cancer: an effective liquid biopsy approach to identify mutations in genes involved in the Homologous Recombination pathway 192
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 175
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 175
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 173
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer 165
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 160
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 156
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 151
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 150
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? 145
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 138
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 137
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 135
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 130
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 126
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 123
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 120
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors 118
Scientific Communication and oncology – "The bridge between knowledge and patients" 117
null 25
Totale 5.738
Categoria #
all - tutte 18.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 22 40
2021/2022303 29 49 9 18 8 24 10 23 28 34 23 48
2022/2023450 41 61 13 64 38 62 36 43 53 6 16 17
2023/2024341 13 31 22 36 28 63 62 14 7 12 8 45
2024/20251.185 36 51 61 58 56 88 190 112 73 152 157 151
2025/20262.761 262 123 178 256 285 498 433 248 232 170 76 0
Totale 5.738